A Study to Compare Safety and Efficacy of OPT-80(Fidaxomicin) With Vancomycin in Subjects With Clostridium Difficile-associated Diarrhea (CDAD)
Clinical trial NCT02179658 · COMPLETED
Trial details
- NCT number
- NCT02179658
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-23
- Primary completion
- 2016-09-08
- Enrollment
- 210
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.